4//SEC Filing
Wulf John William 4
Accession 0001209191-23-019726
CIK 0001831097other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:56 PM ET
Size
12.8 KB
Accession
0001209191-23-019726
Insider Transaction Report
Form 4
Wulf John William
Director
Transactions
- Exercise/Conversion
Options (Rights to Buy)
2023-03-15−80,000→ 120,000 totalExercise: $4.50Exp: 2030-05-22→ Common Stock (80,000 underlying) - Sale
Common Stock
2023-03-15$23.82/sh−80,000$1,905,224→ 123,392 total - Exercise/Conversion
Common Stock
2023-03-15$4.50/sh+80,000$360,000→ 203,392 total
Footnotes (3)
- [F1]Includes restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.68 to $23.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]These options were granted on May 22, 2020, and vest on the first five anniversaries of the grant date, subject to continued service as a director.
Issuer
agilon health, inc.
CIK 0001831097
Entity typeother
Related Parties
1- filerCIK 0001856345
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:56 PM ET
- Size
- 12.8 KB